Update on IBD

Raymond Cross, MD
University of Maryland School of Medicine
University of Maryland Medical Center
Baltimore, MD

Didactic Lecture

Viewing Options


Topic Information

Target Audience

This enduring activity has been designed to meet the educational needs of gastroenterologists, physician assistants, and nurse practitioners involved in the management of inflammatory bowel disease.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Describe the utility of molecular and serologic markers in patients with IBD

Discuss the value of deep remission as a framework for guiding therapy

Identify decision points, medication options, and the risks and benefits of various strategies in patients failing initial or later-line treatment

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and the GI Health Foundation. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

To Participate and Claim Credit

View the internet based webcast via up to date browser. Achieve a 70% passing grade on post-test. Complete and return Evaluation/Request for Credit Form. Certificate of Credit or Participation will be sent via email within 4-6 weeks.

Credit Designation

Purdue University College of Pharmacy designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s) . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Release Date: April 25, 2015Expiration Date: April 25, 2016   
*This program has expired. CME credit is no longer available.

Faculty Disclosure Statement

All faculty and staff involved in the planning or presentation of the continuing education activities provided by Purdue University, College of Pharmacy are required to disclose to the audience all relevant financial relationships with any commercial interest that may pose a conflict with the principles of balance and independence of the activity content. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. The Focus Medical Communications staff and Purdue University, College of Pharmacy staff have no relationships to disclose.

Faculty Disclosure

Grants/Research Support: AbbVie, Janssen, Shire
Consultants/Speaker Bureau: AbbVie, Janssen, Takeda
Honorarium Recipient: AbbVie, Janssen, Takeda

This program is supported by Educational grants from AbbVie, Janssen Biotech, Inc., Prometheus Laboratories and Takeda Pharmaceuticals International, Inc., US Region.

© Copyright 2013-2020 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.